Search

The Nobel Prize for Medicine has again been awarded jointly, this time for miRNA discovery and its role in gene regulation

Steve Bates gives us the inside scoop on the UK’s Vaccine Taskforce.

The Medicine Maker and NIBRT present the Biopharma Trends Leaders’ Report 2022.

From StomachSim, to taste masking, to micronization; check out our special eBook on Formulation

CPHI Milan 2024, the premier global event for pharmaceutical professionals, will take place October 8-10 at Fiera Milano.

develop mRNA-based vaccines for influenza. This early work would eventually pave the way for a COVID-19 vaccine. Pfizer and BioNTech announced a letter of intent to co-develop a COVID-19 vaccine on March 17, [...] revenue in 2021: 18.9 billion euros Other recent news BioNTainer modular mRNA manufacturing solution launched to support scalable vaccine production in Africa Company has expanded collaboration with Regeneron [...] Research collaboration with Matinas BioPharma announced to evaluate novel delivery technology for mRNA vaccines Three-year collaboration announced with Medigene to develop T-cell receptor based immunotherapies

Our latest news roundup reports on a new blow for Harvard, how Pfizer and Astellas’ Xtandi improves cancer survival, and more.

The COVID-19 vaccines demonstrate what’s possible when disease is tackled as a genuine priority.

Never before has the industry moved so rapidly to find new treatments and vaccines – but safety and efficacy must remain top priorities.

Looking for an adaptable screening approach for lipid nanoparticle R&D?